Today, senior representatives from the U.S. Food and Drug Administration (FDA) and the National Institute on Aging at the National Institutes of Health (NIH) joined with advocates, federal colleagues, researchers, and industry to explore collaborations for advancing the most up-to-date knowledge in Alzheimer’s disease research.
Atrial Fibrillation Awareness Month campaign highlights the risks associated with AFib and encourages doctors and patients to take steps toward preventing strokes.